A Deleterious Mutation in SAMD9 Causes Normophosphatemic Familial Tumoral Calcinosis
- 1 October 2006
- journal article
- Published by Elsevier BV in American Journal of Human Genetics
- Vol. 79 (4), 759-764
- https://doi.org/10.1086/508069
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Polypeptide GalNAc-transferase T3 and Familial Tumoral CalcinosisJournal of Biological Chemistry, 2006
- Calcinosis in Rheumatic DiseasesSeminars in Arthritis and Rheumatism, 2005
- A Novel GALNT3 Mutation in a Pseudoautosomal Dominant Form of Tumoral Calcinosis: Evidence That the Disorder Is Autosomal RecessiveJournal of Clinical Endocrinology & Metabolism, 2005
- A Novel Recessive Mutation in Fibroblast Growth Factor-23 Causes Familial Tumoral CalcinosisJournal of Clinical Endocrinology & Metabolism, 2005
- Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disordersJournal of Molecular Medicine, 2004
- An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemiaHuman Molecular Genetics, 2004
- Cutaneous deposition diseases. Part IIJournal of the American Academy of Dermatology, 1998
- Mutations in PEX1 are the most common cause of peroxisome biogenesis disordersNature Genetics, 1997
- SAM as a protein interaction domain involved in developmental regulationProtein Science, 1997
- Tumoral calcinosis revisited ? common and uncommon featuresEuropean Journal of Pediatrics, 1988